1. Epigenetic Optical Mapping of 5-Hydroxymethylcytosine in Nanochannel Arrays
    Tslil Gabrieli et al, 2018, ACS Nano CrossRef
  2. 5hmC Level Predicts Biochemical Failure Following Radical Prostatectomy in Prostate Cancer Patients with ERG Negative Tumors
    Gitte Kristensen et al, 2019, International Journal of Molecular Sciences CrossRef
  3. Deoxyribonucleic Acid 5-Hydroxymethylation in Cell-Free Deoxyribonucleic Acid, a Novel Cancer Biomarker in the Era of Precision Medicine
    Ling Xu et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
  4. 5-Hydroxymethylcytosine in Cell-Free DNA Predicts Immunotherapy Response in Lung Cancer
    Jianming Shao et al, 2024, Cells CrossRef
  5. Elevated FUS/TLS expression is negatively associated with E‑cadherin expression and prognosis of patients with non‑small cell lung cancer
    Dian Xiong et al, 2018, Oncology Letters CrossRef
  6. Loss of Dnmt3a and Dnmt3b does not affect epidermal homeostasis but promotes squamous transformation through PPAR-γ
    Lorenzo Rinaldi et al, 2017, eLife CrossRef
  7. The deficiency of 5-methylcytosine (5mC) and its ramification in the occurrence and prognosis of colon cancer
    Xin-Xin Yan et al, 2023, Medicine CrossRef
  8. TP53 inactivation and expression of methylation-associated proteins in gastric adenocarcinoma with enteroblastic differentiation
    Noboru Yatagai et al, 2019, Virchows Archiv CrossRef
  9. The role of DNA methylation and hydroxymethylation in immunosenescence
    Nicholas D. Johnson et al, 2019, Ageing Research Reviews CrossRef
  10. 5-Hydroxymethylcytosine: the many faces of the sixth base of mammalian DNA
    Edita Kriukienė et al, 2024, Chemical Society Reviews CrossRef
  11. DNA hydroxymethylation of colorectal primary carcinoma and its association with survival
    Anjing Zhong et al, 2018, Journal of Surgical Oncology CrossRef
  12. Ten–eleven translocase: key regulator of the methylation landscape in cancer
    Jyoti Shekhawat et al, 2021, Journal of Cancer Research and Clinical Oncology CrossRef
  13. Solid-state nanopore analysis of human genomic DNA shows unaltered global 5-hydroxymethylcytosine content associated with early-stage breast cancer
    Osama K. Zahid et al, 2021, Nanomedicine: Nanotechnology, Biology and Medicine CrossRef
  14. Oxidized C5-methyl cytosine bases in DNA: 5-Hydroxymethylcytosine; 5-formylcytosine; and 5-carboxycytosine
    Arne Klungland et al, 2017, Free Radical Biology and Medicine CrossRef
  15. Profiling of epigenetic DNA modifications by advanced liquid chromatography-mass spectrometry technologies
    Weiyi Lai et al, 2019, TrAC Trends in Analytical Chemistry CrossRef
  16. 5-Methylcytosine and 5-Hydroxymethylcytosine Signatures Underlying Pediatric Cancers
    Shalu Jhanwar et al, 2019, Epigenomes CrossRef
  17. Determination of cytidine modifications in human urine by liquid chromatography - Mass spectrometry analysis
    Yu-Fan Zhang et al, 2019, Analytica Chimica Acta CrossRef
  18. 5-hydroxymethylcytosine Marks Mammalian Origins Acting as a Barrier to Replication
    Terezia Prikrylova et al, 2019, Scientific Reports CrossRef
  19. Dysregulation and prognostic potential of 5-methylcytosine (5mC), 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC) levels in prostate cancer
    Tine Maj Storebjerg et al, 2018, Clinical Epigenetics CrossRef
  20. Cell-Free DNA 5-Hydroxymethylcytosine Signatures for Lung Cancer Prognosis
    Jianming Shao et al, 2024, Cells CrossRef
  21. Overexpression of RNF187 induces cell EMT and apoptosis resistance in NSCLC
    Zhongming Fu et al, 2019, Journal of Cellular Physiology CrossRef
  22. The TET enzymes
    Peppi Koivunen et al, 2018, Cellular and Molecular Life Sciences CrossRef
  23. Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science
    Yuening Xiang et al, 2019, Cancer Medicine CrossRef
  24. Quantitation and mapping of the epigenetic marker 5‐hydroxymethylcytosine
    Ying Qing et al, 2017, BioEssays CrossRef